Cytokine function in medication-naive first episode psychosis: A systematic review and meta-analysis

Cited by (501)

Items 201–300 of 501

1. Treating cognitive impairment in schizophrenia with GLP-1RAs: an overview of their therapeutic potential
   Jonathan Martin Flintoff, James P. Kesby, Dan J. Siskind, Thomas H.J. Burne · 2021 · Expert Opinion on Investigational Drugs
2. Potential diagnostic biomarkers for schizophrenia
   Weihua Yue, Hailiang Huang, Jubao Duan · 2022 · Medical Review
3. Transdiagnostic inflammatory subgroups among psychiatric disorders and their relevance to role functioning: a nested case-control study of the ALSPAC cohort
   Jonah F. Byrne, Colm Healy, David Mongan, Subash Raj Susai, Stanley Zammit, Melanie Föcking, Mary D Cannon, David Cotter · 2022 · Translational Psychiatry
4. Immune and oxidative stress biomarkers in pediatric psychosis and psychosis-risk: Meta-analyses and systematic review
   Jerome H. Taylor, Julieta Bermúdez-Gómez, Marina Zhou, Óscar Gómez, Casey Ganz-Leary, Cesar Palacios, Zeeshan M. Huque, Ran Barzilay, David R. Goldsmith, Raquel E. Gur · 2023 · Brain Behavior and Immunity
5. Kynurenine is correlated with IL-1β in plasma of schizophrenia patients
   Helena Passarelli Giroud Joaquim, Alana C. Costa, Wagner F. Gattaz, Leda Leme Talib · 2018 · Journal of Neural Transmission
6. Alteration of Serum Levels of Cytokines in Schizophrenic Patients before and after Treatment with Risperidone
   Esfandiar Azizi, Ahmad Zavaran Hosseini, Sara Soudi, Ahmad Ali Noorbala · 2019 · Iranian Journal of Allergy Asthma and Immunology
7. Effects of Mongolian Warm Acupuncture on iNOS/NO and Inflammatory Cytokines in the Hippocampus of Chronic Fatigue Rats
   Ling Shui, Ru-Na Yi, Yong-Jie Wu, Shu‐Mei Bai, Qin Si, Agula Bo, Gerile Wuyun, Lengge Si, Ying-Song Chen, Jun Lü · 2020 · Frontiers in Integrative Neuroscience
8. Association between circulating levels of C-reactive protein and positive and negative symptoms of psychosis in adolescents in a general population birth cohort
   Golam Mohammed Khandaker, Jan Štochl, Stanley Zammit, Glyn Lewis, Robert Dantzer, Peter Brian Jones · 2020 · Journal of Psychiatric Research
9. BDNF in antipsychotic naive first episode psychosis: Effects of risperidone and the immune-inflammatory response system
   Mariane Nunes Noto, Michael H. J. Maes, Sandra Odebrecht Vargas Nunes, Vanessa Ota, Daniel Azevedo Cavalcante, Giovany Oliveira, Ana Carolina Rossaneis, Waldiceu Aparecido Verri Jr, Quirino Cordeiro, Sintia Iole Belangero et al. · 2021 · Journal of Psychiatric Research
10. Characterization of a Novel Mutation in SLC1A1 Associated with Schizophrenia
    Parisa Afshari, Marina Myles‐Worsley, Ori S. Cohen, Josepha Tiobech, Stephen V. Faraone, William Byerley, Frank A. Middleton · 2015 · Complex Psychiatry
11. An exploratory study of immune markers in acute and transient psychosis
    Jayant Mahadevan, Aparna Sundaresh, Ravi Philip Rajkumar, Avin Muthuramalingam, Vikas Menon, Vir Singh Negi, M. G. Sridhar · 2016 · Asian Journal of Psychiatry
12. Reduced Slc1a1 expression is associated with neuroinflammation and impaired sensorimotor gating and cognitive performance in mice: Implications for schizophrenia
    Parisa Afshari, Wei‐Dong Yao, Frank A. Middleton · 2017 · PLoS ONE
13. Deconstructing Schizophrenia: Advances in Preclinical Models for Biomarker Identification
    Judith A. Pratt, BRIAN J. MORRIS, Neil Dawson · 2018 · Current topics in behavioral neurosciences
14. Correlations between immune and metabolic serum markers and schizophrenia/bipolar disorder polygenic risk score in first‐episode psychosis
    Carlo Maj, Sarah Tosato, Roberta Zanardini, Antonio Lasalvia, Angela Favaro, Emanuela Leuci, Giovanni de Girolamo, Mirella Ruggeri, Massimo Gennarelli, the GET‐UP GROUP et al. · 2019 · Early Intervention in Psychiatry
15. First-episode psychosis
    Jyoti Prakash, Kaushik Chatterjee, Kalpana Srivastava, Vinay Singh Chauhan · 2021 · Industrial Psychiatry Journal
16. Prenatal and Childhood Immuno-Metabolic Risk Factors for Adult Depression and Psychosis
    Nils Kappelmann, Benjamin I. Perry, Golam Mohammed Khandaker · 2022 · Harvard Review of Psychiatry
17. Protocol for the Psychosis Immune Mechanism Stratified Medicine (PIMS) trial: a randomised double-blind placebo-controlled trial of single-dose tocilizumab in patients with psychosis
    Éimear M. Foley, Siân Lowri Griffiths, Alexander Murray, Jack C Rogers, Fabiana Maria das Graças Corsi Zuelli, Hannah Hickinbotham, Ella Warwick, Martin Wilson, Muzaffer Kaşer, Graham K. Murray et al. · 2023 · BMJ Open
18. Socioeconomic Disadvantage Moderates the Association between Peripheral Biomarkers and Childhood Psychopathology
    Rodrigo Barbachan Mansur, Graccielle Rodrigues da Cunha, Elson de Miranda Asevedo, André Zugman, Maiara Zeni‐Graiff, Adiel Carneiro Rios, Sumit Sethi, Pawan Kumar Maurya, Mateus Luz Levandowski, Ary Gadelha et al. · 2016 · PLoS ONE
19. Delusions in Context
    Lisa Bortolotti · 2018 · Springer eBooks
20. The Predictive Value of Endothelial Inflammatory Markers in the Onset of Schizophrenia
    G Radu, Constantin Tudor Luca, Lucian Petrescu, Diana-Aurora Arnăutu, Mirela Tomescu, Minodora Andor, Ioana Mihaela Citu, Adelina Mavrea, Valentina Oana Buda, Cătălin Tomescu et al. · 2020 · Neuropsychiatric Disease and Treatment
21. A Marked Low-Grade Inflammation and a Significant Deterioration in Metabolic Status in First-Episode Schizophrenia: A Five-Year Follow-Up Study
    Madis Parksepp, Liina Haring, Kalle Kilk, Egon Taalberg, Raul Kangro, Mihkel Zilmer, Eero Vasar · 2022 · Metabolites
22. Evidence of innate immune dysfunction in first-episode psychosis patients with accompanying mood disorder
    Heather K. Hughes, Houa T. Yang, Tyler A. Lesh, Cameron S. Carter, Paul Ashwood · 2022 · Journal of Neuroinflammation
23. Anhedonia as a Potential Transdiagnostic Phenotype With Immune-Related Changes in Recent-Onset Mental Health Disorders
    Paris Alexandros Lalousis, Aanya Malaviya, Ali Khatibi, Majid Saberi, Lana Kambeitz‐Ilankovic, Shalaila S. Haas, Stephen James Wood, Nicholas M. Barnes, Jack C Rogers, Katharine Chisholm et al. · 2024 · Biological Psychiatry
24. Associations between in vivo neuroimaging and postmortem brain cytokine markers in a rodent model of Wernicke's encephalopathy
    Natalie May Zahr, Carsten Alt, Dirk Mayer, Torsten Rohlfing B, Amy Manning-Bog, Richard H. Luong, Edith V. Sullivan, Adolf Pfefferbaum · 2014 · Experimental Neurology
25. Associations between soluble urokinase plasminogen activator receptor (suPAR) concentration and psychiatric disorders – A systematic review and meta-analysis
    Jennifer Murphy, Anna Zierotin, David Mongan, Colm Healy, Subash Raj Susai, Brian N. O'Donoghue, Mary Clarke, K. O’Connor, Mary D Cannon, David Cotter · 2024 · Brain Behavior and Immunity
26. Fingolimod ameliorates schizophrenia‐like cognitive impairments induced by phencyclidine in male rats
    Xueli Yu, Xueyu Qi, Wei Long, Liansheng Zhao, Wei Deng, Wanjun Guo, Qiang Wang, Xiaohong Ma, Xun Hu, Peiyan Ni et al. · 2022 · British Journal of Pharmacology
27. Kynurenine pathway dynamics in patients with schizophrenia spectrum disorders across the disease trajectory
    Carolin Kuuskmäe, Mari‐Anne Philips, Kalle Kilk, Liina Haring, Raul Kangro, Indrek Seppo, Mihkel Zilmer, Eero Vasar · 2023 · Psychiatry Research
28. Gut permeability and mimicry of the Glutamate Ionotropic Receptor NMDA type Subunit Associated with protein 1 (GRINA) as potential mechanisms related to a subgroup of people with schizophrenia with elevated antigliadin antibodies (AGA IgG)
    Daniela Čiháková, William W. Eaton, Monica Vladut Talor, Uasim H. Harkus, Haley K. Demyanovich, Katrina M. Rodriguez, Stephanie M. Feldman, Deanna L. Kelly · 2019 · Schizophrenia Research
29. Serum inflammatory markers and their associations with white matter integrity of the corpus callosum in schizophrenia patients and healthy controls
    Anna Michalczyk, Ernest Marek Tyburski, Piotr Podwalski, Katarzyna Waszczuk, Krzysztof Rudkowski, Jolanta Kucharska–Mazur, Monika Mak, Katarzyna Rek-Owodziń, Piotr Plichta, Maksymilian Bielecki et al. · 2022 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
30. Plasma cytokines in minimally treated schizophrenia
    Sunil V. Kalmady, Venkataram Shivakumar, Dania Alphonse Jose, Vasanthapuram Ravi, Matcheri S. Keshavan, Bangalore N. Gangadhar, Ganesan Venkatasubramanian · 2018 · Schizophrenia Research
31. Promoter Polymorphisms of TNF-α Gene as a Risk Factor for Schizophrenia
    Renata Suchanek-Raif, Paweł Raif, Małgorzata Kowalczyk, Monika Paul-Samojedny, Krzysztof Artur Kucia, Wojciech Merk, Jan Kowalski · 2018 · Archives of Medical Research
32. Environmental Exposures and Neuropsychiatric Disorders: What Role Does the Gut–Immune–Brain Axis Play?
    Shannon Delaney, Mady Hornig · 2018 · Current Environmental Health Reports
33. Inhibition of the dopamine transporter as an animal model of bipolar disorder mania: Locomotor response, neuroimmunological profile and pharmacological modulation
    Juliana dos Reis Bastos, Katherinne Manrique Perico, Érica Leandro Marciano Vieira, Antônio Lúcio Teixeira, Fabiana Simão Machado, Aline Silva de Miranda, Fabrício A. Moreira · 2018 · Journal of Psychiatric Research
34. Effects of fingolimod, a sphingosine-1-phosphate (S1P) receptor agonist, on white matter microstructure, cognition and symptoms in schizophrenia
    Michael Francis, Tom A. Hummer, Emily Liffick, Jenifer L. Vohs, Nikki F. Mehdiyoun, Andrew C. Visco, Ziyi Yang, Richard J. Kovacs, Ying Zhang, Alan F. Breier · 2020 · Brain Imaging and Behavior
35. Correlation between elevated serum interleukin-1β, interleukin-16 levels and psychiatric symptoms in patients with schizophrenia at different stages
    Xialong Cheng, Yu Xie, Anzhen Wang, Cuizhen Zhu, Fanfan Yan, Wenzhi Pei, Xulai Zhang · 2023 · BMC Psychiatry
36. Variations of blood D-serine and D-aspartate homeostasis track psychosis stages
    Antonio Rampino, Martina Garofalo, Tommaso Nuzzo, Maria Favia, Silvia Saltarelli, Rita Masellis, Martina Grazia Asselti, Teresa Claudia Pennacchio, Dario Bruzzese, Francesco Errico et al. · 2024 · Schizophrenia
37. Cerebrospinal fluid microglia and neurodegenerative markers in twins concordant and discordant for psychotic disorders
    Viktoria Johansson, Joel Jakobsson, Rebecca G. Fortgang, Henrik Zetterberg, Kaj Blennow, Tyrone D. Cannon, Christina M. Hultman, Lennart Wetterberg, Mikael Landén · 2016 · European Archives of Psychiatry and Clinical Neuroscience
38. Cognitive and inflammatory heterogeneity in severe mental illness: Translating findings from blood to brain
    Linn Sofie Sæther, Attila Szabó, Ibrahim A. Akkouh, Beathe C. Haatveit, Christine Mohn, Anja Vaskinn, Pål Aukrust, Monica B E G Ormerod, Nils Eiel Steen, Ingrid S. Melle et al. · 2024 · Brain Behavior and Immunity
39. Protein Profiles and Novel Molecular Biomarkers of Schizophrenia Based on 4D-DIA Proteomics
    Hui-ping Shen, Xiaotao Dong, Zhibin Li, Jingzhu Wu, Chunmei Zheng, Xie-jun Hu, Chao Qian, S. Wang, Yu-long Zhao, Ji‐Cheng Li · 2024 · Journal of Proteome Research
40. Neuroinflammation and kynurenines in schizophrenia: Impact on cognition depending on cognitive functioning and modulatory properties in relation to cognitive remediation and aerobic exercise
    Jacopo Sapienza, Giulia Agostoni, Stefano Comai, Sofia Nasini, Stefano Dall’Acqua, Stefania Sut, Marco Spangaro, Francesca Martini, Margherita Bechi, Mariachiara Buonocore et al. · 2024 · Schizophrenia Research Cognition
41. Effects of 6-week olanzapine treatment on serum IL-2, IL-4, IL-8, IL-10, and TNF-α levels in drug-naive individuals with first-episode schizophrenia
    Xiaofeng Zhao, Wenli Zhu, Yangying Bu, Junwei Li, Yihui Hao, Yuxiao Bi · 2024 · BMC Psychiatry
42. Interleukin-3, symptoms and cognitive deficits in first-episode drug-naïve and chronic medicated schizophrenia
    Meihong Xiu, Dong Wang, Song Chen, Xiang-Dong Du, Da-Chun Chen, Nan Chen, Yue-Chan Wang, Guangzhong Yin, Yingyang Zhang, Yun-Long Tan et al. · 2018 · Psychiatry Research
43. Immunity and psychiatric disorders: variabilities of immunity biomarkers are they specific?
    Thomas Dubois, Christine Reynaert, Denis Jacques, Brice Lepièce, Pierre Patigny, Nicolas Zdanowicz · 2018 · PubMed
44. Spirulina platensis reduces the schizophrenic-like symptoms in rat model by restoring altered APO-E and RTN-4 protein expression in prefrontal cortex
    Saida Haider, Sidrah Shahzad, Zehra Batool, Sadia Sadir, Laraib Liaquat, Saiqa Tabassum, Tahira Perveen · 2021 · Life Sciences
45. Associations Between the Kynurenine Pathway, Proinflammatory Cytokines, and Brain-Derived Neurotrophic Factor in Hospitalized Patients With Chronic Schizophrenia: A Preliminary Study
    Naomichi Okamoto, Tomoya Natsuyama, Ryohei Igata, Yuki Konishi, Hirofumi Tesen, Atsuko Ikenouchi, Reiji Yoshimura · 2021 · Frontiers in Psychiatry
46. State marker properties of niacin skin sensitivity in ultra-high risk groups for psychosis - An optical reflection spectroscopy study
    Kerstin Langbein, Ulrike Schmidt, Stephan Schack, Natalie Joan Biesel, Maria Rudzok, G. Paul Amminger, Maximus Berger, Heinrich Sauer, Stefan Smesny · 2017 · Schizophrenia Research
47. Dopamine and Neuroinflammation in Schizophrenia – Interpreting the Findings from Translocator Protein (18kDa) PET Imaging
    Sotiria Maria Iliopoulou, Stergios Tsartsalis, Stefan Kaiser, P. Millet, Benjamin B. Tournier · 2021 · Neuropsychiatric Disease and Treatment
48. A Cross-Sectional Study on Associations Between BDNF, CRP, IL-6 and Clinical Symptoms, Cognitive and Personal Performance in Patients With Paranoid Schizophrenia
    Egor M. Chumakov, Mariia Dorofeikova, Цыренова Кристина Александровна, Nataliia Petrova · 2022 · Frontiers in Psychiatry
49. Network analysis of inflammation and symptoms in recent onset schizophrenia and the influence of minocycline during a clinical trial
    Sarah E. Herniman, Stephen James Wood, Golam Mohammed Khandaker, Paola Dazzan, Carmine Maria Pariante, Nicholas M. Barnes, Carl R. Krynicki, Naghmeh Nikkheslat, Rachel C. Vincent, Alexander Roberts et al. · 2023 · Translational Psychiatry
50. Multivariate analyses of immune markers reveal increases in plasma EN-RAGE in first-episode psychosis patients
    Laura Korhonen, Elisabeth R. Paul, Karin Wåhlén, Liina Haring, Eero Vasar, Antti I. Vaheri, Dan Lindholm · 2023 · Translational Psychiatry
51. Tumor necrosis factor‐alpha −1031T/C polymorphism is associated with cognitive deficits in chronic schizophrenia patients versus healthy controls
    Mei Hong Xiu, Lijuan Man, Dong Wang, Xiangdong Du, Guangzhou Yin, Yingyang Zhang, Yun Tan, Nan Chen, Song Chen, Antônio Lúcio Teixeira et al. · 2018 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
52. ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis
    Sue Cotton, M. Berk, Amity Watson, Stephen James Wood, Kelly Allott, Cali Bartholomeusz, Chiara C. Bortolasci, Ken R. Walder, Brian N. O'Donoghue, Olivia May Dean et al. · 2019 · Trials
53. Active psychosis and pro-inflammatory cytokines in first-episode of psychosis
    G. Pardo de Santayana, María Juncal‐Ruíz, Javier Vázquez-Bourgón, Laura Riesco-Dávila, Víctor Ortiz‐García de la Foz, José María Pelayo‐Terán, Marcos López‐Hoyos, Benedicto Crespo‐Facorro · 2020 · Journal of Psychiatric Research
54. A population-based follow-up study shows high psychosis risk in women with PCOS
    Salla Karjula, Riikka K. Arffman, Laure C. Morin-Papunen, Stephen Franks, Marjo‐Riitta Järvelin, Juha S. Tapanainen, Jouko Miettunen, Terhi Piltonen · 2021 · Archives of Women s Mental Health
55. Common mechanisms for type 2 diabetes and psychosis: Findings from a prospective birth cohort
    Benjamin Ian Perry, Hannah J Jones, Tom G. Richardson, Stanley Zammit, Nicholas J. Wareham, Glyn Lewis, Peter Brian Jones, Golam Mohammed Khandaker · 2020 · Schizophrenia Research
56. The Role of Aberrations in the Immune-inflammatory Reflex System (IRS) and the Compensatory Immune-regulatory Reflex System (CIRS) in Different Phenotypes of Schizophrenia: The IRS-CIRS Theory of Schizophrenia
    Chutima Roomruangwong, Cristiano de Souza Noto, Buranee Kanchanatawan, George Anderson, Marta Kubera, Andre Ferrer Carvalho, Michael H. J. Maes · 2018 · Preprints.org
57. Overexpression of transmembrane TNFα in brain endothelial cells induces schizophrenia-relevant behaviors
    In Jun Yeo, Jaesuk Yun, Dong Ju Son, Sang‐Bae Han, Maree J. Webster, Jin Tae Hong, Sanghyeon Kim · 2022 · Molecular Psychiatry
58. Prolactin and morning cortisol concentrations in antipsychotic naïve first episode psychosis: A systematic review and meta-analysis
    Clàudia Aymerich, Borja Pedruzo, Malein Pacho, María Laborda, Jon Herrero, Toby Pillinger, Robert Ali McCutcheon, Daniel Alonso Alconada, Marta Bordenave, Maria Martínez-Querol et al. · 2023 · Psychoneuroendocrinology
59. Psychedelics and schizophrenia: a double-edged sword
    Jacopo Sapienza, Francesca Martini, Stefano Comai, Roberto Cavallaro, Marco Spangaro, Danilo De Gregorio, Marta Bosia · 2024 · Molecular Psychiatry
60. Serum soluble urokinase-type plasminogen activator receptor levels in male patients with acute exacerbation of schizophrenia
    Abdullah Genç, Tevfik Kalelioğlu, Nesrin Karamustafalıoğlu, Akif Tasdemir, Esra Sena Genc, Mustafa Akkuş, Murat Emül · 2016 · Psychiatry Research
61. The independent and combined effects of cannabis use and systemic inflammation during the early stages of psychosis: exploring the two-hit hypothesis
    Fabiana Maria das Graças Corsi Zuelli, Leonardo André da Costa Marques, Daiane Leite da Roza, Camila Marcelino Loureiro, Rosana Shuhama, Marta Di Forti, Paulo Rossi Menezes, Paulo Louzada‐Júnior, Cristina Marta Del‐Ben · 2021 · Psychological Medicine
62. mRNA Expression of the CUB and Sushi Multiple Domains 1 (CSMD1) and Its Serum Protein Level as Predictors for Psychosis in the Familial High-Risk Children and Young Adults
    Eman Masoud Abd El Gayed, Mohamed S. Rizk, Ahmed Nabil Ramadan, Noha Rabie Bayomy · 2021 · ACS Omega
63. Convergent lines of evidence supporting involvement of NFKB1 in schizophrenia
    Jing Long, Lin Tian, Ancha V. Baranova, Hongbao Cao, Yao Yao, Shuquan Rao, Fuquan Zhang · 2022 · Psychiatry Research
64. Hypothesis: High salt intake as an inflammation amplifier might be involved in the pathogenesis of neuropsychiatric disorders
    Amir Abdoli · 2017 · Clinical and Experimental Neuroimmunology
65. Metabolic Dysregulation and Psychosocial Stress in Patients with Schizophrenia Spectrum Disorders: A Case-Control Study
    B. Misiak, P. Piotrowski, J. Beszłej, S. Kalinowska, Magdalena Chec, J. Samochowiec · 2020 · Journal of Clinical Medicine
66. Paliperidone Reversion of Maternal Immune Activation-Induced Changes on Brain Serotonin and Kynurenine Pathways
    Karina S. MacDowell, Eva Munarriz‐Cuezva, J. Javier Meana, Juan Carlos Leza, Jorge Emilio Ortega · 2021 · Frontiers in Pharmacology
67. The relationship between psychopathology and cognitive functions with cytokines in clinically stable patients with schizophrenia
    Serhat Ergün, Ömer Yanartaş, Güler Kandemir, Ahmad El Yaman, Mesut Yıldız, Goncagül Haklar, Kemal Sayar · 2017 · Psychiatry and Clinical Psychopharmacology
68. Normal human CD4+ helper T cells express Kv1.1 voltage-gated K+ channels, and selective Kv1.1 block in T cells induces by itself robust TNFα production and secretion and activation of the NFκB non-canonical pathway
    Barbara Fellerhoff-Losch, Sergiy V. Korol, Yonatan Ganor, Songhai Gu, Itzik Cooper, Raya Eilam, Michal Judith Besser, Meidan Goldfinger, Yehuda Chowers, Rudolf Wank et al. · 2015 · Journal of Neural Transmission
69. Association between C-reactive protein levels and antipsychotic treatment during 12 months follow-up period after acute psychosis
    Farivar Fathian, Rolf Gjestad, Rune A. Kroken, Else‐Marie Løberg, Solveig Klæbo Reitan, W. Wolfgang Fleichhacker, Maria A. Rettenbacher, Tor Ketil Larsen, Inge Joa, Lena Antonsen Stabell et al. · 2022 · Schizophrenia Research
70. Peripheral Complement Factor-Based Biomarkers for Patients with First-Episode Schizophrenia
    Yin Cao, Yayun Xu, Qingrong Xia, Feng Shan, Jun Liang · 2023 · Neuropsychiatric Disease and Treatment
71. MicroRNAs and pro-inflammatory cytokines as candidate biomarkers for recent-onset psychosis
    Ali Reza Shafiee‐Kandjani, Negin Nezhadettehad, Sara Farhang, Richard Bruggeman, Dariush Shanebandi, Mohammadbagher Hassanzadeh, Hosein Azizi · 2023 · BMC Psychiatry
72. Decreased Plasma Levels of Kynurenine and Kynurenic Acid in Previously Treated and First-Episode Antipsychotic-Naive Schizophrenia Patients
    M. Marković, Nataša Petronijević, M. Stašević, Ivana Stašević Karličić, M. Velimirović, T. Stojković, S. Ristić, M. Stojković, Natasa M. Milic, Tatjana Nikolić · 2023 · Cells
73. Association between triglyceride glucose index (TyG) and psychotic symptoms in patients with first-episode drug-naïve major depressive disorder
    Junjun Liu, Yangchun Wang, Wei Mu, Yang Liu, Ruixiang Tong, Zhaomin Lu, Hsinsung Yuan, Fengnan Jia, Xiaobin Zhang, Zhe Li et al. · 2024 · Frontiers in Psychiatry
74. Targeting the Immune System With Pharmacotherapy in Schizophrenia
    Jennifer K. Melbourne, Benjamin Feiner, Cherise Rosen, Rajiv P. Sharma · 2017 · Current Treatment Options in Psychiatry
75. An integrative study of the microbiome gut-brain-axis and hippocampal inflammation in psychosis: Persistent effects from mode of birth
    Peter Joe, José C. Clemente, Enrica Piras, David S. Wallach, Jessica Robinson‐Papp, Emeka Boka, Brooke Remsen, Mharisi Bonner, David Kimhy, Deborah M. Goetz et al. · 2021 · Schizophrenia Research
76. Hippocampal Proteomic and Metabonomic Abnormalities in Neurotransmission, Oxidative Stress, and Apoptotic Pathways in a Chronic Phencyclidine Rat Model
    Hendrik Wesseling, Elizabeth J. Want, Paul C. Guest, Hassan Rahmoune, Elaine C. Holmes, Sabine Bahn · 2015 · Journal of Proteome Research
77. Elevated levels of Insulin-like Growth Factor-1 (IGF-1) in drug-naïve patients with psychosis
    Petros Petrikis, Vassiliki A. Boumba, Alexandros T. Tzallas, Paraskevi V. Voulgari, Dimitra T. Archimandriti, Petros Skapinakis, Venetsanos G. Mavreas · 2016 · Psychiatry Research
78. Prognostic models predicting transition to psychotic disorder using blood-based biomarkers: a systematic review and critical appraisal
    Jonah F. Byrne, David Mongan, Jennifer Murphy, Colm Healy, Melanie Föcking, Mary D Cannon, David Cotter · 2023 · Translational Psychiatry
79. The Interrelationships between Cytokines and Schizophrenia: A Systematic Review
    Haibing Lv, Meng Guo, Guo Chuang, Kuanjun He · 2024 · International Journal of Molecular Sciences
80. Differential Macrophage Responses in Affective Versus Non-Affective First-Episode Psychosis Patients
    Heather K. Hughes, Emily Mills-Ko, Houa T. Yang, Tyler A. Lesh, Cameron S. Carter, Paul Ashwood · 2021 · Frontiers in Cellular Neuroscience
81. Metabolic pathways in the periphery and brain: Contribution to mental disorders?
    Andrzej Nagalski, Kamil Koziński, Marta Barbara Wisniewska · 2016 · The International Journal of Biochemistry & Cell Biology
82. A molecular pathway analysis stresses the role of inflammation and oxidative stress towards cognition in schizophrenia
    Ellen Kure Fischer, Antonio Drago · 2017 · Journal of Neural Transmission
83. Potential application of helminth therapy for resolution of neuroinflammation in neuropsychiatric disorders
    Amir Abdoli, Hoda Mirzaian Ardakani · 2019 · Metabolic Brain Disease
84. Neuropsychiatric disorders: An immunological perspective
    Ernest Aw, Yingying Zhang, Esra Yalçın, U. Herrmann, Michael C. Carroll · 2021 · Advances in immunology
85. Inflammation is associated with avolition and reduced resting state functional connectivity in corticostriatal reward circuitry in patients with schizophrenia
    David R. Goldsmith, Courtney S. Ning, Gregory P. Strauss, Robin E. Gross, Jessica A. Cooper, Evanthia C. Wommack, Ebrahim Haroon, Jennifer C. Felger, Elaine F. Walker, Michael Tilghman Treadway et al. · 2025 · Neuropsychopharmacology
86. Body fluid biomarkers and psychosis risk in The Accelerating Medicines Partnership® Schizophrenia Program: design considerations
    Diana O. Perkins, Clark D. Jeffries, Scott Richard Clark, Rachel Upthegrove, Cassandra Wannan, Naomi R. Wray, Qingqin S. Li, Kim Q., Elaine F. Walker, G. Paul Amminger et al. · 2025 · Schizophrenia
87. Pharmacotherapy of schizophrenia: immunological aspects and potential role of immunotherapy
    Prerna Chauhan, Gurjit Kaur, Rajendra Prasad, Harmanjit Singh · 2021 · Expert Review of Neurotherapeutics
88. Differential Sphingosine-1-Phosphate Receptor-1 Protein Expression in the Dorsolateral Prefrontal Cortex Between Schizophrenia Type 1 and Type 2
    Ganesh B. Chand, Hao Jiang, J. Philip Miller, C. Harker Rhodes, Zhude Tu, Dean Foster Wong · 2022 · Frontiers in Psychiatry
89. Serum levels of interleukin 6 in schizophrenic patients during treatment augmentation with sarcosine (results of the PULSAR study)
    Dominik Strzelecki, Małgorzata Urban‐Kowalczyk, Adam Wysokiński · 2018 · Human Psychopharmacology Clinical and Experimental
90. Correlation between C-reactive protein and the inflammatory ratios in acute schizophrenia inpatients: are they associated?
    Llorca-Bofí, Vicent, Bioque, Miquel, Font, Maria, Gich, Ignasi, Mur, Maria · 2023 · Journal of Psychiatric Research
91. Serum Interleukin-6 in Schizophrenia: Associations with Clinical and Sociodemographic Characteristics
    Tatyana Vladimirovna Zhilyaeva, Grigory V. Rukavishnikov, Elvira A. Manakova, Galina Elevna Mazo · 2023 · Consortium Psychiatricum
92. SEP‐363856 exerts neuroprotection through the PI3K/AKT/GSK‐3β signaling pathway in a dual‐hit neurodevelopmental model of schizophrenia‐like mice
    Mengdie Li, Yunxiao Liu, Meng Sun, Yating Yang, Ling Zhang, Yuexia Liu, Fujin Li, Huanzhong Liu · 2024 · Drug Development Research
93. Psychosis of Epilepsy: An Update on Clinical Classification and Mechanism
    Zhiruo Qiu, Jiahui Guo, Bofei Chen, Jiajia Fang · 2025 · Biomolecules
94. Inflammation in Schizophrenia: The Role of Disordered Oscillatory Mechanisms
    Lucinda J. Speers, David K. Bilkey · 2025 · Cells
95. Evidence for increased immune mobilization in First Episode Psychosis compared with the prodromal stage in males
    Evangelos Karanikas, Ioannis Griveas, Evangelos Ntouros, Georgios D. Floros, George Garyfallos · 2016 · Psychiatry Research
96. Comparison of thin-strut cobalt-chromium stents and stainless steel stents in a porcine model of neointimal hyperplasia.
    Krzysztof P. Milewski, Aleksander Żurakowski, Jacek Pająk, Ewa Pajak-Zielinska, Łukasz Liszka, Piotr Paweł Buszman, Jarosław Bis, Marcin Dębiński, Paweł Eugeniusz Buszman · 2010 · PubMed
97. Altered Autonomic Function in Individuals at Clinical High Risk for Psychosis
    Anna Kocsis, Ruchika Gajwani, Joachim Groß, Andrew Ian Gumley, Stephen M. Lawrie, Matthias Schwannauer, Frauke Schultze‐Lutter, Tineke Grent-‘t-Jong, Peter J. Uhlhaas · 2020 · Frontiers in Psychiatry
98. Association study between genetic variants and the risk of schizophrenia in the Chinese population based on GWAS-implicated 6p21.3–23.1 human genome region: a case-control study
    Gangqin Li, Jie Dai, Hao Liu, Yushan Lin, Qiaoni Liu, Kaiyuan Zheng, Suyu Li, Siyu Chen, Yi Ye · 2021 · BMC Psychiatry
99. Predictors of successful anti-inflammatory drug trials in patients with schizophrenia: A meta-regression and critical commentary
    Anjali Chandra, Brian J. Miller, David R. Goldsmith · 2023 · Brain Behavior and Immunity
100. Changes in the cytokine profile in first-episode, drug-naïve patients with psychosis after short-term antipsychotic treatment
     Petros Petrikis, Paraskevi V. Voulgari, Alexandros T. Tzallas, Vassiliki A. Boumba, Dimitra T. Archimandriti, Dimitrios Zambetas, Ioannis A. Papadopoulos, Ioannis G. Tsoulos, Petros Skapinakis, Venetsanos G. Mavreas · 2017 · Psychiatry Research